Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2016 2
2017 5
2018 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Redirecting T cells to hematological malignancies with bispecific antibodies.
Velasquez MP, Bonifant CL, Gottschalk S. Velasquez MP, et al. Blood. 2018 Jan 4;131(1):30-38. doi: 10.1182/blood-2017-06-741058. Epub 2017 Nov 8. Blood. 2018. PMID: 29118005 Free PMC article. Review.
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, Gaikwad A, Nguyen P, Arber C, Song XT, Redell M, Gottschalk S. Bonifant CL, et al. Among authors: velasquez mp. Mol Ther. 2016 Sep 29;24(9):1615-26. doi: 10.1038/mt.2016.116. Epub 2016 Jun 6. Mol Ther. 2016. PMID: 27401038 Free PMC article.
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
Velasquez MP, Szoor A, Vaidya A, Thakkar A, Nguyen P, Wu MF, Liu H, Gottschalk S. Velasquez MP, et al. Cancer Immunol Res. 2017 Oct;5(10):860-870. doi: 10.1158/2326-6066.CIR-17-0171. Epub 2017 Aug 18. Cancer Immunol Res. 2017. PMID: 28821531 Free PMC article.
Advances in immunotherapy for pediatric acute myeloid leukemia.
Bonifant CL, Velasquez MP, Gottschalk S. Bonifant CL, et al. Among authors: velasquez mp. Expert Opin Biol Ther. 2018 Jan;18(1):51-63. doi: 10.1080/14712598.2018.1384463. Epub 2017 Oct 11. Expert Opin Biol Ther. 2018. PMID: 28945115 Review.
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond.
Epperly R, Gottschalk S, Velasquez MP. Epperly R, et al. Among authors: velasquez mp. Children (Basel). 2020 Feb 17;7(2):14. doi: 10.3390/children7020014. Children (Basel). 2020. PMID: 32079207 Free PMC article. Review.
Targeting CD19: the good, the bad, and CD81.
Velasquez MP, Gottschalk S. Velasquez MP, et al. Blood. 2017 Jan 5;129(1):9-10. doi: 10.1182/blood-2016-11-749143. Blood. 2017. PMID: 28057672 Free PMC article.
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Szoor A, Vaidya A, Velasquez MP, Mei Z, Galvan DL, Torres D, Gee A, Heczey A, Gottschalk S. Szoor A, et al. Among authors: velasquez mp. Mol Ther Oncolytics. 2017 Jul 28;6:69-79. doi: 10.1016/j.omto.2017.07.002. eCollection 2017 Sep 15. Mol Ther Oncolytics. 2017. PMID: 28856237 Free PMC article.
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies.
Velasquez MP, Torres D, Iwahori K, Kakarla S, Arber C, Rodriguez-Cruz T, Szoor A, Bonifant CL, Gerken C, Cooper LJ, Song XT, Gottschalk S. Velasquez MP, et al. Sci Rep. 2016 Jun 3;6:27130. doi: 10.1038/srep27130. Sci Rep. 2016. PMID: 27255991 Free PMC article.
Improving care for children with sickle cell disease/acute chest syndrome.
Crabtree EA, Mariscalco MM, Hesselgrave J, Iniguez SF, Hilliard TJ, Katkin JP, McCarthy K, Velasquez MP, Airewele G, Hockenberry MJ. Crabtree EA, et al. Among authors: velasquez mp. Pediatrics. 2011 Feb;127(2):e480-8. doi: 10.1542/peds.2010-3099. Epub 2011 Jan 17. Pediatrics. 2011. PMID: 21242225
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing.
Riberdy JM, Zhou S, Zheng F, Kim YI, Moore J, Vaidya A, Throm RE, Sykes A, Sahr N, Bonifant CL, Ryu B, Gottschalk S, Velasquez MP. Riberdy JM, et al. Among authors: velasquez mp. Mol Ther Methods Clin Dev. 2020 Jun 30;18:571-581. doi: 10.1016/j.omtm.2020.06.024. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32775492 Free PMC article.
Feedback